STRIPE CONSULTING LIMITED

Financial Health Score: B (Good with minor concerns)

Explanation: Stripe Consulting Limited possesses a remarkably strong constitution, evidenced by a robust balance sheet with over £2.5 million in net assets and zero long-term debt. However, its financial vitals showed significant deterioration in 2022, with a severe drop in revenue and a collapsing gross profit margin. While the company's accumulated reserves act as an excellent immune system against immediate threats, the 2022 performance indicates an acute operational illness that requires prompt treatment to prevent long-term decline.

Key Vital Signs

1. Blood Pressure (Liquidity & Cash): Healthy * Cash Position: Increased from £97,321 in 2021 to £438,783 in 2022. The company is well-hydrated with a strong cash pulse. * Current Ratio: Current assets (£3.23M) outweigh current liabilities (£718k) by more than 4.5 to 1. The company has more than enough short-term resources to cover its immediate obligations.

2. Cholesterol Levels (Trade Receivables): Elevated / Blocked Arteries * Debtors: Trade and other receivables stand at a staggering £2.79 million against a revenue of £1.83 million. This means the company has over a year’s worth of revenue tied up in unpaid invoices. This financial "plaque" restricts the healthy flow of cash, even though the bank balance currently looks healthy.

3. Weight & Muscle Mass (Revenue & Profitability): Rapid Wasting * Revenue: Dropped 25% from £2.45M in 2021 to £1.83M in 2022. The business has lost its appetite. * Gross Profit Margin: Plummeted from a healthy 47.8% in 2021 to a worrying 24.8% in 2022. Cost of sales increased by nearly £100k despite revenue falling by over £600k. This indicates severe margin pressure or significant project cost overruns. * Operating Profit: Collapsed from £913,285 in 2021 to just £178,090 in 2022.

4. Bone Density (Net Assets & Equity): Very Strong * Net Assets: Grew from £2.40M to £2.55M. The business has accumulated substantial retained earnings (£2.54M) over its lifetime, providing a very thick cushion against current operational shocks.

Diagnosis

Stripe Consulting Limited is suffering from an acute margin contraction and revenue atrophy, set against a background of underlying structural strength.

The primary symptom of concern is the gross margin collapse. In 2021, for every £1 of revenue, the company retained roughly 48p as gross profit. In 2022, this fell to under 25p. In a structural engineering consultancy, this usually indicates one of three conditions: taking on unprofitable projects just to keep busy, severe cost overruns on fixed-price contracts, or increased subcontractor costs that could not be passed on to the client.

Furthermore, the "blocked arteries" represented by the £2.79M in trade receivables are concerning. While it is common in engineering to have long payment cycles or retention monies held by clients, carrying nearly 18 months' worth of revenue in debtors suggests a systemic issue with collections or an over-reliance on a small number of slow-paying clients (potentially related to the parent company entities listed in the PSC register).

Fortunately, the patient’s "immune system" is incredibly strong. With £2.5M in retained earnings, no long-term debt, and a positive cash balance, the company is in no immediate danger of insolvency. However, living off accumulated fat (reserves) rather than fresh nutritional intake (current profits) is unsustainable in the long run.

Recommendations

1. Clear the Arteries (Improve Debt Collection): Implement a rigorous credit control regimen. With £2.79M tied up in receivables, accelerating collections by even 10-15% would dramatically boost cash flow and reduce the need to rely on cash reserves to fund ongoing operations.
2. Review the Diet (Assess Project Pricing): Conduct a post-mortem on the 2022 projects to understand why the gross margin halved. The business must ensure it is pricing new contracts accurately and not taking on loss-making work simply to maintain revenue volume.
3. Monitor the Vitals Closely: While the 2022 drop in profit is concerning, one year does not necessarily make a chronic condition. Compare the 2023 figures closely to see if the margin drop was a one-off infection (a specific bad contract) or a chronic disease (a shift in the market requiring a permanent change in operating model).
4. Leverage the Constitution: With a very strong balance sheet and supportive parent companies (as indicated by the PSC register), the business is well-positioned to invest in business development to win higher-margin work, rather than relying on cost-cutting alone to recover profitability.